Cholesteryl ester transfer protein as a potential therapeutic target to improve the HDL to LDL cholesterol ratio

被引：12
|
作者：
Sikorski, JA [1 ]
Glenn, KC [1 ]
机构：
[1] Pharmacia Discovery Res, St Louis, MO 63198 USA
来源：
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 35 | 2000年 / 35卷
关键词：
D O I：
10.1016/S0065-7743(00)35023-0
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：251 / 260
页数：10
相关论文
共 50 条
  • [31] Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia
    Le Goff, W
    Guerin, M
    Chapman, MJ
    PHARMACOLOGY & THERAPEUTICS, 2004, 101 (01) : 17 - 38
  • [32] TRANSFER OF CHOLESTERYL ESTER FROM HDL TO LDL BY A CETP-INDEPENDENT PATHWAY IN MICE
    Amar, M.
    Stonick, J.
    Remaley, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [33] Plasma adiponectin is associated with HDL cholesterol independently of the cholesteryl ester transfer process
    Dullaart, R. P. F.
    Perton, F.
    de Vries, R.
    van Tol, A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 : 51 - 51
  • [34] Variability of the gene coding for cholesteryl ester transfer protein influences the response of transfer activity and HDL-cholesterol to alcohol
    Toury, I
    Zahouani, A
    Husson, M
    Schellenberg, F
    Fumeron, F
    Betoulle, D
    Vacher, D
    Lamisse, F
    Girard-Globa, A
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 1998, 8 (04) : 185 - 191
  • [35] A role of phospholipid transfer protein and cholesteryl ester transfer protein in cholesterol efflux
    Tchoua, U
    Escher, G
    Maugeais, C
    Sviridov, D
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (05) : E91 - E91
  • [36] Remodeling of the HDL in NIDDM: a fundamental role for cholesteryl ester transfer protein
    Castle, CK
    Kuiper, SL
    Blake, WL
    Paigen, B
    Marotti, KR
    Melchior, GW
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1998, 274 (06): : E1091 - E1098
  • [37] Downregulation of cholesteryl ester transfer protein by glucocorticoids: a randomised study on HDL
    Buning, Jorien Werumeus
    Dimova, Lidya G.
    Perton, Frank G.
    Tietge, Uwe J. F.
    van Beek, Andre P.
    Dullaart, Robin P. F.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 (07) : 494 - 503
  • [38] Antiproteinuric therapy decreases LDL-cholesterol as well as HDL-cholesterol in non-diabetic proteinuric patients: relationships with cholesteryl ester transfer protein mass and adiponectin
    Krikken, J. A.
    Waanders, F.
    Dallinga-Thie, G. M.
    Dikkeschei, L. D.
    Vogt, L.
    Navis, G. J.
    Dullaart, R. P. F.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (05) : 497 - 504
  • [39] TRANSFER OF CHOLESTERYL ESTER INTO HIGH-DENSITY LIPOPROTEIN BY CHOLESTERYL ESTER TRANSFER PROTEIN - EFFECT OF HDL LIPID AND APOPROTEIN CONTENT
    SPARKS, DL
    PRITCHARD, PH
    JOURNAL OF LIPID RESEARCH, 1989, 30 (10) : 1491 - 1498
  • [40] EFFECT OF UNESTERIFIED CHOLESTEROL ON THE ACTIVITY OF CHOLESTERYL ESTER TRANSFER PROTEIN
    RAJARAM, OV
    CHAN, RYS
    SAWYER, WH
    BIOCHEMICAL JOURNAL, 1994, 304 : 423 - 430
12345